Manmohini Pharmaceuticals Private Limited
About Manmohini Pharmaceuticals Private Limited
Data last updated:
Manmohini Pharmaceuticals Private Limited is a private limited company based in Murshidabad, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52100WB2013PTC194498.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Nmg Realcon Private Limited and Manmohinin Pharmaceuticals Private Limited. It is led by directors Bijay Kumar Gulgulia and Sushma Devi Gulgulia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24/A/B/15 Kalikapore Road Shilpataluk Berhampore, Murshidabad, West Bengal, India – 742101.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.21 Cr. For the same year it recorded a net profit of ₹49.39 Lakh (net margin 22.4%) and EBITDA of ₹68.33 Lakh (EBITDA margin 30.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Manmohini Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Nmg Realcon Private Limited, and Manmohinin Pharmaceuticals Private Limited. The current legal name is Manmohini Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Manmohini Pharmaceuticals Private Limited | Current |
| Nmg Realcon Private Limited | Previous |
| Manmohinin Pharmaceuticals Private Limited | Previous |
CIN history
Manmohini Pharmaceuticals has one previous CIN (Corporate Identification Number): U45400WB2013PTC194498. The current CIN is U52100WB2013PTC194498, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U52100WB2013PTC194498 | Current |
| U45400WB2013PTC194498 | Previous |
Contact details
Manmohini Pharmaceuticals Private Limited's registered office is in Murshidabad, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address24/A/B/15 Kalikapore Road Shilpataluk Berhampore, Murshidabad, West Bengal, India – 742101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Manmohini Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Manmohini Pharmaceuticals Private Limited
FY 2025 filings availableManmohini Pharmaceuticals Private Limited reported revenue of ₹2.21 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹68.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.9% | ||||
| Net Profit Margin | 22.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manmohini Pharmaceuticals Private Limited, buy the company report.
Board of directors of Manmohini Pharmaceuticals Private Limited
Manmohini Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bijay Kumar Gulgulia | Director | 05 Mar 2022 | 4 Years 8 Months | Current |
| Sushma Devi Gulgulia | Director | 05 Mar 2022 | 4 Years 8 Months | Current |
Peer comparison
Manmohini Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jyoti Capsules Private Limited | ₹2.22 Cr (FY 2025) | 11886.0% | Uttar Pradesh, India | |||
| Upthink Solutions Private Limited | ₹2.22 Cr (FY 2025) | 84.0% | Hyderabad, Telangana, India | |||
| Keron Lifesciences Private Limited | ₹2.21 Cr (FY 2025) | 6.0% | Dehradun, Uttarakhand, India | |||
| Norman Pharmaceuticals Private Limited | ₹2.21 Cr (FY 2023) | 43.0% | Mumbai, Maharashtra, India | |||
| Prevoir Healthcare Private Limited | ₹2.21 Cr (FY 2025) | 199.0% | Pune, Maharashtra, India | |||
| Manmohini Pharmaceuticals Private Limitedthis company | ₹2.21 Cr (FY 2025) | ₹49.39 Lakh | 22.4% | Murshidabad, West Bengal, India | ||
| Mendel Pharma Private Limited | ₹2.21 Cr (FY 2024) | 1.0% | Hyderabad, Telangana, India | |||
| Indinex Private Limited | ₹2.21 Cr (FY 2018) | -81.0% | Navi Mumbai, Maharashtra, India | |||
| Scion Pharma Private Limited | ₹2.21 Cr (FY 2025) | 41.0% | Gandhinagar, Gujarat, India | |||
| Cinicot Private Limited | ₹2.21 Cr (FY 2024) | -82.0% | Mohali, Punjab, India | |||
| Geneka Pharmaceuticals Private Limited | ₹2.21 Cr (FY 2025) | Haridwar, Uttarakhand, India |
To see the full peer comparison of Manmohini Pharmaceuticals Private Limited, buy the company report.
Auditor
Manmohini Pharmaceuticals Private Limited is audited by LALIT KUMAR PERIWAL & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LALIT KUMAR PERIWAL & COMPANY | FY 2022 | 325872E |
Shareholding
The shareholding of Manmohini Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Manmohini Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Manmohini Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manmohini Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Manmohini Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Manmohini Pharmaceuticals Private Limited has 8 board changes on record since 2013: 5 appointments and 3 cessations. The latest: Surendra Kumar Gulgulia ceased to be Director on 25 Nov 2022.
Frequently asked questions
Manmohini Pharmaceuticals is an active private limited company based in Murshidabad, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 June 2013 (13+ years old) and is registered under CIN U52100WB2013PTC194498.
Manmohini Pharmaceuticals has 2 current directors:
- Bijay Kumar Gulgulia - Director
- Sushma Devi Gulgulia - Director
The latest financial statements of Manmohini Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Manmohini Pharmaceuticals is U52100WB2013PTC194498. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manmohini Pharmaceuticals was incorporated on 11 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Manmohini Pharmaceuticals by revenue are Jyoti Capsules Private Limited, Upthink Solutions Private Limited, Keron Lifesciences Private Limited, Norman Pharmaceuticals Private Limited, Prevoir Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Surendra Kumar Gulgulia ceased to be Director on 25 Nov 2022. Mahendra Kumar Gulgulia ceased to be Director on 12 Mar 2022. Bijay Kumar Gulgulia was appointed as Director on 05 Mar 2022. Manmohini Pharmaceuticals has 8 board changes on record in total.
The registered office of Manmohini Pharmaceuticals is at 24AB15 Kalikapore Road Shilpataluk Berhampore, Murshidabad, West Bengal, India – 742101.
Manmohini Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Manmohini Pharmaceuticals is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.
Yes. Manmohini Pharmaceuticals was formerly known as Nmg Realcon Private Limited, Manmohinin Pharmaceuticals Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
